Molecular Templates Inc (MTEM)
NASDAQ:MTEM
US Market
Holding MTEM?
Track your performance easily

Molecular Templates (MTEM) Stock Forecast & Price Target

536 Followers
See the Price Targets and Ratings of:

MTEM Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Molecular
Templates
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MTEM Stock 12 Month Forecast

There Are No Analyst Ratings for MTEM In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MTEM Financial Forecast

MTEM Earnings Forecast

Next quarter’s earnings estimate for MTEM is -$1.03 with a range of -$1.03 to -$1.03. The previous quarter’s EPS was -$1.23. MTEM beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year MTEM has Outperformed its overall industry.
Next quarter’s earnings estimate for MTEM is -$1.03 with a range of -$1.03 to -$1.03. The previous quarter’s EPS was -$1.23. MTEM beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year MTEM has Outperformed its overall industry.

MTEM Sales Forecast

Next quarter’s sales forecast for MTEM is $330.00K with a range of $330.00K to $330.00K. The previous quarter’s sales results were $572.00K. MTEM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year MTEM has Outperformed its overall industry.
Next quarter’s sales forecast for MTEM is $330.00K with a range of $330.00K to $330.00K. The previous quarter’s sales results were $572.00K. MTEM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.45% of the time in the same period. In the last calendar year MTEM has Outperformed its overall industry.

MTEM Analyst Recommendation Trends

Rating
Mar 22
May 22
Jul 22
Aug 22
Nov 22
Strong Buy
0
0
0
1
2
Buy
6
4
4
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
1
1
1
0
total
6
5
5
4
3
In the current month, MTEM has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MTEM average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

MTEM Stock Forecast FAQ

What is MTEM’s average 12-month price target, according to analysts?
Currently, no data Available
What is MTEM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for MTEM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is MTEM a Buy, Sell or Hold?
      Currently, no data Available
      What is Molecular Templates Inc’s price target?
      Currently, no data Available
      What do analysts say about Molecular Templates Inc?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of MTEM?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis